One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Inside This Issue
doi : 10.1016/S1936-8798(21)00132-1
Volume 14, Issue 4, 22 February 2021, Pages A12-A17
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management
Felice Gragnano, Mattia Branca, Enrico Frigoli, Sergio Leonardi, Marco Valgimigli
doi : 10.1016/j.jcin.2020.11.042
Volume 14, Issue 4, 22 February 2021, Pages 361-373
The aim of this study was to assess the impact of access-site crossover in patients with acute coronary syndrome undergoing invasive management via radial or femoral access.
Impact of Crossover: A Consideration for Initial Access Site Selection?
John W. Hirshfeld, David P. Faxon, David O. Williams
doi : 10.1016/j.jcin.2020.12.028
Volume 14, Issue 4, 22 February 2021, Pages 374-377
Distal Radial Artery Approach to Prevent Radial Artery Occlusion Trial
Guering Eid-Lidt, Agust?n Rivera Rodr?guez, Joaqu?n Jimenez Castellanos, Julio I. Farjat Pasos, Jorge Gaspar
doi : 10.1016/j.jcin.2020.10.013
Volume 14, Issue 4, 22 February 2021, Pages 378-385
The aim of this study was to compare the rate of proximal radial artery occlusion (RAO) with Doppler ultrasound between distal and conventional radial access 24 h and 30 days after a transradial coronary procedure.
Distal Radial Approach: The Next Promising Step in an Even More Minimally Invasive Strategy?
Ivo Bernat
doi : 10.1016/j.jcin.2020.11.005
Volume 14, Issue 4, 22 February 2021, Pages 386-387
Hemoglobin A1c and Cardiovascular Outcomes Following Percutaneous Coronary Intervention: Insights From a Large Single-Center Registry
Usman Baber, Lorenzo Azzalini, Reza Masoomi, Gurpreet Johal, Samin K. Sharma
doi : 10.1016/j.jcin.2020.10.008
Volume 14, Issue 4, 22 February 2021, Pages 388-397
The aim of this study was to evaluate post–percutaneous coronary intervention (PCI) outcomes in relation to pre-procedural glycated hemoglobin (HbA1c) levels from a large, contemporary cohort.
Glucose Control in Patients Undergoing PCI: What Is the Optimal HbA1c for Long-Term Outcomes??
Sotirios Tsimikas, Harpreet S. Bhatia
doi : 10.1016/j.jcin.2020.11.038
Volume 14, Issue 4, 22 February 2021, Pages 398-400
Outcomes of Operator-Directed Sedation and Anesthesiologist Care in the Pediatric/Congenital Catheterization Laboratory: A Study Utilizing Data From the IMPACT Registry
Michael L. O’Byrne, Kevin F. Kennedy, James M. Steven, Kevin D. Hill, Andrew C. Glatz
doi : 10.1016/j.jcin.2020.10.054
Volume 14, Issue 4, 22 February 2021, Pages 401-413
The objective of this study was to assess contemporary use of operator directed sedation (ODS) and anesthesiologist care (AC) in the pediatric/congenital cardiac catheterization laboratory (PCCL), specifically evaluating whether the use of operator-directed sedation was associated with increased risk of major adverse events.
Operator-Directed Sedation in the Pediatric Cardiac Catheterization Laboratory: “The Wheel Has Come Full Circle”?†
Lee Benson, Bruce Macpherson
doi : 10.1016/j.jcin.2020.11.023
Volume 14, Issue 4, 22 February 2021, Pages 414-416
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES
Katherine H. Chau, Ajay J. Kirtane, Rachel M. Easterwood, Bj?rn Redfors, Gregg W. Stone
doi : 10.1016/j.jcin.2020.12.005
Volume 14, Issue 4, 22 February 2021, Pages 417-427
The aim of this study was to determine the risk period for increased stent thrombosis (ST) after percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) and whether this increased risk is related to high platelet reactivity (HPR).
Is This a Good Time to Revisit the Tropics?: Platelet Function Testing in Patients With Acute Coronary Syndromes?
Neal S. Kleiman
doi : 10.1016/j.jcin.2020.12.041
Volume 14, Issue 4, 22 February 2021, Pages 428-430
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction
Seung-Jun Lee, Jae Young Cho, Byeong-Keuk Kim, Kyeong Ho Yun, Yangsoo Jang
doi : 10.1016/j.jcin.2020.11.036
Volume 14, Issue 4, 22 February 2021, Pages 431-440
The aim of this study was to assess whether the effects of ticagrelor monotherapy after 3-month dual-antiplatelet therapy (DAPT) are consistent among patients presenting with ST-segment elevation myocardial infarction (STEMI), non–ST-segment elevation myocardial infarction, and unstable angina treated with drug-eluting stents.
Aspirin-Free Strategies in ACS: Is It the Drug or the Stent??
Michel Zeitouni, Paul Guedeney
doi : 10.1016/j.jcin.2020.12.040
Volume 14, Issue 4, 22 February 2021, Pages 441-443
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis
Marco Valgimigli, Roxana Mehran, Anna Franzone, Bruno R. da Costa, Stephan Windecker
doi : 10.1016/j.jcin.2020.11.046
Volume 14, Issue 4, 22 February 2021, Pages 444-456
The aim of this study was to compare ticagrelor monotherapy with dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stents.
Ticagrelor Monotherapy After Coronary Stenting: Like a Twilight Through the Looking Glass?
Dirk Sibbing, Salvatore Cassese
doi : 10.1016/j.jcin.2020.12.039
Volume 14, Issue 4, 22 February 2021, Pages 457-460
Stenting “Vulnerable” But Fractional Flow Reserve–Negative Lesions: Potential Statistical Limitations of Ongoing and Future Trials
Frederik M. Zimmermann, Nico H.J. Pijls, K. Lance Gould, Nils P. Johnson
doi : 10.1016/j.jcin.2020.05.036
Volume 14, Issue 4, 22 February 2021, Pages 461-467
Can imaging provide sufficient risk stratification to warrant revascularization of a stable plaque with negative fractional flow reserve (FFR)? Prophylactic stenting could at best be applied selectively since the composite group of FFR-negative lesions has a death or myocardial infarction rate of approximately 1%/year or less but modern stents have a rate of 2% to 3.5%/year.
Potential of an Approach Based on the Identification and Treatment of Vulnerable Coronary Plaques
Francesco Prati, Eloisa Arbustini, Fernando Alfonso
doi : 10.1016/j.jcin.2020.12.033
Volume 14, Issue 4, 22 February 2021, Pages 468-473
In this viewpoint paper, the authors are tackling criticism to the limits of invasive imaging modalities for identification and treatment of vulnerable plaques. They believe in the clinical usefulness of invasive imaging modalities for identification of vulnerable plaques, and are suggesting an explanation for the suboptimal results of past studies, that failed to demonstrate a correlation between interventional treatment of vulnerable plaques, and reduction of hard clinical endpoints.
Comparison of Intravascular Ultrasound and Optical Coherence Tomography Images of Calcified Lesions During Rotational Atherectomy
Kensuke Yokoi, Daisuke Nakamura, Isamu Mizote, Tatsuya Shiraki, Yasushi Sakata
doi : 10.1016/j.jcin.2020.11.019
Volume 14, Issue 4, 22 February 2021, Pages 474-475
Left Main Ischemia as First Manifestation of Aortic Dissection
Youssef S. Abdelwahed, Alberto C. Weber, Patrick T. Siegrist
doi : 10.1016/j.jcin.2020.11.016
Volume 14, Issue 4, 22 February 2021, Pages 476-480
OCT and IVUS Appearance of a Neointimal Dissection Within a Recently Implanted Left Main Stent
Yann Shan Keh, Chee Yang Chin, Adrian F. Low, Khung Keong Yeo
doi : 10.1016/j.jcin.2020.11.017
Volume 14, Issue 4, 22 February 2021, Pages e31-e35
Post-Sternotomy Internal Mammary Artery Pseudoaneurysm
Koichi Inoue, Satoshi Kainuma, Eiji Kashiwagi, Koichi Toda, Yoshiki Sawa
doi : 10.1016/j.jcin.2020.11.037
Volume 14, Issue 4, 22 February 2021, Pages e37-e38
Intravascular Ultrasound Findings of BioGlue Surgical Adhesive Coronary Embolism After Ascending Aorta Replacement
Masashi Yokoi, Hiroshi Fujita, Tatsuhito Ogawa, Tsuyoshi Ito, Nobuyuki Ohte
doi : 10.1016/j.jcin.2020.11.018
Volume 14, Issue 4, 22 February 2021, Pages e39-e41
DOACs for AF After TAVR: Are DOACs Really on First Base?
Abhishek C. Sawant, Michael Megaly, Ashish Pershad
doi : 10.1016/j.jcin.2020.12.016
Volume 14, Issue 4, 22 February 2021, Page 481
Reply: DOACs for AF After TAVR: Are DOACs Really on First Base?
HideyukiKawashimaMDYusukeWatanabeMD, PhDHirofumiHiokiMDKenKozumaMD, PhDMasanoriYamamotoMD, PhDKentaroHayashidaMD, PhD
doi : 10.1016/j.jcin.2020.12.030
Volume 14, Issue 4, 22 February 2021, Pages 481-482
Absolute Blood Flow in the Left Main Coronary Artery and Its Distribution
Alessandro Candreva, Emanuele Gallinoro, Stéphane Fournier, Elena Izaga, Alejandro Gutiérrez-Barrios
doi : 10.1016/j.jcin.2020.11.043
Volume 14, Issue 4, 22 February 2021, Pages 482-484
Timing of Coronary Revascularization and Transcatheter Aortic Valve Replacement: An Observational Nationwide Cohort Analysis
Pierre Lantelme, Arnaud Bisson, Thibaud Lacour, Julien Herbert, Laurent Fauchier
doi : 10.1016/j.jcin.2020.11.040
Volume 14, Issue 4, 22 February 2021, Pages 484-486
The Clinical Outcomes of Fractional Flow Reserve–Based Deferred Revascularization of Coronary Lesions in Patients on Hemodialysis
Hisao Otsuki, Junichi Yamaguchi, Junya Matsuura, Yusuke Inagaki, Nobuhisa Hagiwara
doi : 10.1016/j.jcin.2020.12.014
Volume 14, Issue 4, 22 February 2021, Pages 486-488
